protect arabinofuranosylcytosin n-mustard-induc myelotox hemoregulatori peptid pglu-glu-asp-cys-li monom dimer synthet peptid pglu-glu-asp-cys-li peedck monom cytostat drug-induc prolifer hematopoiet stem cell keep cfu- quiescent peedck treatment render cycle-specif cytostat drug toxic peedck applic administr relev nonleth ara-c percentag cfu- s-phase sustain stem cell number bone marrow BM unprotect mice cfu- popul cystein content peedck monom dimer peedck potent stimul hematopoiesi postchemotherapi acceler hematolog recoveri similar use recombin hematopoiet growth factor singl inject micrograms/kg peedck monom hour second ara-c inject onset neutropenia day recoveri depress quantit degre neutropenia postchemotherapi ara-c n-mustard infus stimulatori peedck dimer micrograms/kg/d increas progenitor level BM cell normal mice day end cytostat treatment cfu-gm detect unprotect mice increas sever day granulocyt count high week peripher leukocyt matur polymorphonuclear leukocyt pmn phase ara-c monom treatment dimer infus complet protect hematopoiesi mice protect peedck monom stimulatori dimer leukocyt depress unprotect anim inhibitori monom stem cell popul intact optimum target cell condit subsequ stimul dimer treatment result hemoregulatori peptid monom dimer hematolog statu mice relev dose cytostat drug antimetabolit alkyl combin peptid occurr neutropenia peptid chemic synthesi activ human cell promis candid applic multilevel hemoprotector cancer chemotherapi 